Closed courtneythaxton closed 4 years ago
Scott, when do you anticipate this being available on the website? If it is going to be lengthy amount of time, we may want to add something like: "In the interim, consider mentioning the Classification Contributors in the free text evidence summary to acknowledge their work."
Also, please use "Evidence Repository" instead of "ERepo" in case people don't know what that is.
Erin Rooney Riggs, MS, CGC
Assistant Professor
Certified Genetic Counselor
Autism & Developmental Medicine Institute
Geisinger
eriggs@geisinger.edumailto:eriggs@geisinger.edu
From: Scott G notifications@github.com Sent: Tuesday, December 17, 2019 9:47 PM To: ClinGen/clincoded clincoded@noreply.github.com Cc: Riggs, Erin eriggs@geisinger.edu; Mention mention@noreply.github.com Subject: [External] Re: [ClinGen/clincoded] Secondary approvers and contributors in the GCI (#1796)
I like the version Courtney shared.
Sent from my iPhone
On Dec 17, 2019, at 9:24 PM, courtneythaxton notifications@github.com wrote:
Would you all consider this language? "At present, designation of Classification Contributors is restricted to the VCI/GCI. In the future, Classification Contributors will appear on curation summaries published to the ClinGen website and/or ERepo to facilitate recognition."
— You are receiving this because you were mentioned. Reply to this email directly, view it on GitHub, or unsubscribe.
— You are receiving this because you were mentioned. Reply to this email directly, view it on GitHubhttps://nam05.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgithub.com%2FClinGen%2Fclincoded%2Fissues%2F1796%3Femail_source%3Dnotifications%26email_token%3DAHFJTFC5IUPHD3FWVTBZYY3QZGMNNA5CNFSM4FZLMMN2YY3PNVWWK3TUL52HS4DFVREXG43VMVBW63LNMVXHJKTDN5WW2ZLOORPWSZGOEHEYJTY%23issuecomment-566854863&data=02%7C01%7Ceriggs%40geisinger.edu%7C9a6208ff8569419588ef08d7836d0521%7C37d46c567c664402a16055c2313b910d%7C0%7C0%7C637122376574722300&sdata=2m3cHvUh3MbSdTtdq3BJGRoAfYDzCd5q3F%2B1aqRlkJk%3D&reserved=0, or unsubscribehttps://nam05.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgithub.com%2Fnotifications%2Funsubscribe-auth%2FAHFJTFDJJJXOVDJQEYUPKVTQZGMNNANCNFSM4FZLMMNQ&data=02%7C01%7Ceriggs%40geisinger.edu%7C9a6208ff8569419588ef08d7836d0521%7C37d46c567c664402a16055c2313b910d%7C0%7C0%7C637122376574722300&sdata=paUDxg8vou4jPdXWMfOTp5IIFsU3AbLYkyj38elgsHA%3D&reserved=0.
IMPORTANT WARNING: The information in this message (and the documents attached to it, if any) is confidential and may be legally privileged. It is intended solely for the addressee. Access to this message by anyone else is unauthorized. If you are not the intended recipient, any disclosure, copying, distribution or any action taken, or omitted to be taken, in reliance on it is prohibited and may be unlawful. If you have received this message in error, please delete all electronic copies of this message (and the documents attached to it, if any), destroy any hard copies you may have created and notify me immediately by replying to this email. Thank you. Geisinger Health System utilizes an encryption process to safeguard Protected Health Information and other confidential data contained in external e-mail messages. If email is encrypted, the recipient will receive an e-mail instructing them to sign on to the Geisinger Health System Secure E-mail Message Center to retrieve the encrypted e-mail.
Ok. Great. Thanks guys. Let's go with Courtney's text.
But with "Evidence Repository" instead of "ERepo". So the text would be:
"At present, designation of Classification Contributors is restricted to the GCI. In the future, Classification Contributors will appear on curation summaries published to the ClinGen website and/or Evidence Repository to facilitate recognition."
Regarding Erin’s question.... I see Tristan later today and I can confirm timing because he is tasked with the work needed to consume the data into the service that the website utilizes for display.
Sent from my iPhone
On Dec 17, 2019, at 10:57 PM, ErinRiggs notifications@github.com wrote:
Scott, when do you anticipate this being available on the website? If it is going to be lengthy amount of time, we may want to add something like: "In the interim, consider mentioning the Classification Contributors in the free text evidence summary to acknowledge their work."
Also, please use "Evidence Repository" instead of "ERepo" in case people don't know what that is.
Erin Rooney Riggs, MS, CGC
Assistant Professor
Certified Genetic Counselor
Autism & Developmental Medicine Institute
Geisinger
eriggs@geisinger.edumailto:eriggs@geisinger.edu
From: Scott G notifications@github.com Sent: Tuesday, December 17, 2019 9:47 PM To: ClinGen/clincoded clincoded@noreply.github.com Cc: Riggs, Erin eriggs@geisinger.edu; Mention mention@noreply.github.com Subject: [External] Re: [ClinGen/clincoded] Secondary approvers and contributors in the GCI (#1796)
I like the version Courtney shared.
Sent from my iPhone
On Dec 17, 2019, at 9:24 PM, courtneythaxton notifications@github.com wrote:
Would you all consider this language? "At present, designation of Classification Contributors is restricted to the VCI/GCI. In the future, Classification Contributors will appear on curation summaries published to the ClinGen website and/or ERepo to facilitate recognition."
— You are receiving this because you were mentioned. Reply to this email directly, view it on GitHub, or unsubscribe.
— You are receiving this because you were mentioned. Reply to this email directly, view it on GitHubhttps://nam05.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgithub.com%2FClinGen%2Fclincoded%2Fissues%2F1796%3Femail_source%3Dnotifications%26email_token%3DAHFJTFC5IUPHD3FWVTBZYY3QZGMNNA5CNFSM4FZLMMN2YY3PNVWWK3TUL52HS4DFVREXG43VMVBW63LNMVXHJKTDN5WW2ZLOORPWSZGOEHEYJTY%23issuecomment-566854863&data=02%7C01%7Ceriggs%40geisinger.edu%7C9a6208ff8569419588ef08d7836d0521%7C37d46c567c664402a16055c2313b910d%7C0%7C0%7C637122376574722300&sdata=2m3cHvUh3MbSdTtdq3BJGRoAfYDzCd5q3F%2B1aqRlkJk%3D&reserved=0, or unsubscribehttps://nam05.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgithub.com%2Fnotifications%2Funsubscribe-auth%2FAHFJTFDJJJXOVDJQEYUPKVTQZGMNNANCNFSM4FZLMMNQ&data=02%7C01%7Ceriggs%40geisinger.edu%7C9a6208ff8569419588ef08d7836d0521%7C37d46c567c664402a16055c2313b910d%7C0%7C0%7C637122376574722300&sdata=paUDxg8vou4jPdXWMfOTp5IIFsU3AbLYkyj38elgsHA%3D&reserved=0.
IMPORTANT WARNING: The information in this message (and the documents attached to it, if any) is confidential and may be legally privileged. It is intended solely for the addressee. Access to this message by anyone else is unauthorized. If you are not the intended recipient, any disclosure, copying, distribution or any action taken, or omitted to be taken, in reliance on it is prohibited and may be unlawful. If you have received this message in error, please delete all electronic copies of this message (and the documents attached to it, if any), destroy any hard copies you may have created and notify me immediately by replying to this email. Thank you. Geisinger Health System utilizes an encryption process to safeguard Protected Health Information and other confidential data contained in external e-mail messages. If email is encrypted, the recipient will receive an e-mail instructing them to sign on to the Geisinger Health System Secure E-mail Message Center to retrieve the encrypted e-mail. — You are receiving this because you were mentioned. Reply to this email directly, view it on GitHub, or unsubscribe.
Added as part of Release 30 (R30)
Added as part of Release 30 (R30)
The Biocuration cores (and possible other curation EPs) will need the ability to have a secondary expert panel list for approval of curations, as the cores themselves do not have a broad list of expert for approval, and many of the curations will be sent to other EPs for approval. Recognition for the curation affiliation and approval EP affiliation should translate to the website.
Specifications: (1) Under Approve classification, provide a "Secondary Approver" dropdown list. This list should include all current Affiliations. Potentially add a "Secondary Approver comments section in which the name(s) of the experts for that affiliation can be logged. Secondary Affiliation approval v2.pdf
(2) We would also like this "dual" credit to be recognized on clinical genome.org gene-disease validity classifications (2a) Addition of an area in the classification matrix under "calculated classification" that says curation performed by the following Affiliation: list per the primary approver dropdown (2b) Under the "expert curation (date): Provide the Classification (approved date) and the following text: This gene-disease validity classification was approved by the "name of secondary approver affiliation." Website dual recognition.pdf
If these needs more specification, please advise @wrightmw @jimmyzhen @jennygoldstein @erinriggs @marinadistefano @sgoehringer